How inflammation impinges on NAFLD: A role for Kupffer cells

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Duarte, Nádia ^a,b   Coelho, Inês C ^a,b   Patarrão, Rita S ^a,b   Almeida, Joana I ^b   Penha Gonçalves, Carlos ^b,c   Macedo, M Paula ^a,c  

^a NOVA MEDICAL SCHOOL   (Portugal)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^c Portuguese Diabetes Association Education and Research Center (APDP ERC)   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; KUPFFER CELL; MEDIATOR RELEASE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PATHOGENESIS; REVIEW; STELLATE CELL; LIVER; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR;

HUMANS; INFLAMMATION; INSULIN RESISTANCE; KUPFFER CELLS; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RISK FACTORS;

EID: 84930959966     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/984578     Document Type: Review

References (84)

1. J. D. Browning, L. S. Szczepaniak, R. Dobbins et al., "Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, " Hepatology, vol. 40, no. 6, pp. 1387-1395, 2004.
2. J. B. Schwimmer, R. Deutsch, T. Kahen, J. E. Lavine, C. Stanley, and C. Behling, "Prevalence of fatty liver in children and adolescents, " Pediatrics, vol. 118, no. 4, pp. 1388-1393, 2006.
3. M. Blachier, H. Leleu, M. Peck-Radosavljevic, D.-C. Valla, and F. Roudot-Thoraval, "The burden of liver disease in Europe: a review of available epidemiological data, " Journal of Hepatology, vol. 58, no. 3, pp. 593-608, 2013.
4. K. Tominaga, J. H. Kurata, Y. K. Chen et al., "Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey, " Digestive Diseases and Sciences, vol. 40, no. 9, pp. 2002-2009, 1995.
5. S. Forbes, S. D. Taylor-Robinson, N. Patel, P. Allan, B. R. Walker, and D. G. Johnston, "Increased prevalence of nonalcoholic fatty liver disease in European women with a history of gestational diabetes, " Diabetologia, vol. 54, no. 3, pp. 641-647, 2011.
6. E. M. Koehler, J. N. L. Schouten, B. E. Hansen et al., "Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdamstudy, " Journal ofHepatology, vol. 57, no. 6, pp. 1305-1311, 2012.
7. B. Betzel and J. P. H. Drenth, "A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease?" BMC Medicine, vol. 12, no. 1, article 152, 2014.
8. A. Gastaldelli, M. Kozakova, K. Hojlund et al., "Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population, " Hepatology, vol. 49, no. 5, pp. 1537-1544, 2009.
9. J. C. Cohen, J. D. Horton, and H. H. Hobbs, "Human fatty liver disease: old questions and new insights, " Science, vol. 332, no. 6037, pp. 1519-1523, 2011.
10. D. Q.-H. Wang, P. Portincasa, and B. A. Neuschwander-Tetri, "Steatosis in the Liver, " Comprehensive Physiology, vol. 3, no. 4, pp. 1493-1532, 2013.
11. U. S. Department of Agriculture and U. S. Department of Health and Human Services, in Dietary Guidelines for Americans, pp. 20-32, 2010.
12. N. Gruben, R. Shiri-Sverdlov, D. P. Y. Koonen, andM. H. Hofker, "Nonalcoholic fatty liver disease: a main driver of insulin resistance or a dangerous liaison?" Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1842, no. 11, pp. 2329-2343, 2014.
13. Y. Kawano and D. E. Cohen, "Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease, " Journal of Gastroenterology, vol. 48, no. 4, pp. 434-441, 2013.
14. G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca, "Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes, " Endocrine Reviews, vol. 23, no. 2, pp. 201-229, 2002.
15. K. L. Donnelly, C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt, and E. J. Parks, "Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, " Journal of Clinical Investigation, vol. 115, no. 5, pp. 1343-1351, 2005.
16. R. J. Perry, V. T. Samuel, K. F. Petersen, and G. I. Shulman, "The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes, " Nature, vol. 510, no. 7503, pp. 84-91, 2014.
17. A. S. Greenberg, R. A. Coleman, F. B. Kraemer et al., "The role of lipid droplets in metabolic disease in rodents and humans, " Journal of Clinical Investigation, vol. 121, no. 6, pp. 2102-2110, 2011.
18. J. E. Schaffer, "Lipotoxicity: when tissues overeat, " Current Opinion in Lipidology, vol. 14, no. 3, pp. 281-287, 2003.
19. J. Y. Lee and D. H. Hwang, "The modulation of inflammatory gene expression by lipids: mediation through toll-like receptors, " Molecules and Cells, vol. 21, no. 2, pp. 174-185, 2006.
20. Z. Z. Li, M. Berk, T. M. McIntyre, and A. E. Feldstein, "Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-Coa desaturase, " The Journal of Biological Chemistry, vol. 284, no. 9, pp. 5637-5644, 2009.
21. Y. Noguchi, J. D. Young, J. O. Aleman, M. E. Hansen, J. K. Kelleher, and G. Stephanopoulos, "Effect of anaplerotic fluxes and amino acid availability on hepatic lipoapoptosis, " Journal of Biological Chemistry, vol. 284, no. 48, pp. 33425-33436, 2009.
22. G. Rizki, L. Arnaboldi, B. Gabrielli et al., "Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1, " The Journal of Lipid Research, vol. 47, no. 10, pp. 2280-2290, 2006.
23. M. Pagliassoti, Y. Wei, and D. Wang, "Saturated fatty acids induce cytotoxicity in hepatocytes via effects on the endoplasmic reticulum, " Obesity Research, vol. 13, p. A31, 2005.
24. N. M. Borradaile, X. Han, J. D. Harp, S. E. Gale, D. S. Ory, and J. E. Schaffer, "Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death, " Journal of Lipid Research, vol. 47, no. 12, pp. 2726-2737, 2006.
25. J. Mandl, T. Meszaros, G. Banhegyi, L. Hunyady, and M. Csala, "Endoplasmic reticulum: nutrient sensor in physiology and pathology, " Trends in Endocrinology andMetabolism, vol. 20, no. 4, pp. 194-201, 2009.
26. N. Chalasani, M. A. Deeg, and D. W. Crabb, "Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis systemic lipid peroxidation inNASH, "The American Journal ofGastroenterology, vol. 99, no. 8, pp. 1497-1502, 2004.
27. G. Musso, R. Gambino, F. deMichieli et al., "Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis, " Hepatology, vol. 37, no. 4, pp. 909-916, 2003.
28. N. Chalasani, L. Wilson, D. E. Kleiner, O. W. Cummings, E. M. Brunt, and A. Unalp, "Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease, " Journal of Hepatology, vol. 48, no. 5, pp. 829-834, 2008.
29. P. M. B. Vos, J. E. Kimmons, C. Gillespie, J. Welsh, and H. M. Blank, "Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey, " The Medscape Journal of Medicine, vol. 10, no. 7, article 160, 2008.
30. X. Ouyang, P. Cirillo, Y. Sautin et al., "Fructose consumption as a risk factor for non-alcoholic fatty liver disease, " Journal of Hepatology, vol. 48, no. 6, pp. 993-999, 2008.
31. N. Assy, G. Nasser, I. Kamayse et al., "Soft drink consumation linked with fatty liver in the absence of traditional risk factors, " Canadian Journal of Gastroenterology, vol. 22, no. 10, pp. 811-816, 2008.
32. R. H. Lustig, "Fructose: its alcohol without the buzz, " Advances in Nutrition, vol. 4, no. 2, pp. 226-235, 2013.
33. K. L. Teff, S. S. Elliott, M. Tschop et al., "Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women, " Journal of Clinical Endocrinology andMetabolism, vol. 89, no. 6, pp. 2963-2972, 2004.
34. C. Postic and J. Girard, "Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice, " Journal of Clinical Investigation, vol. 118, no. 3, pp. 829-838, 2008.
35. D. Faeh, K. Minehira, J.-M. Schwarz, R. Periasami, P. Seongsu, and L. Tappy, "Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthymen, " Diabetes, vol. 54, no. 7, pp. 1907-1913, 2005.
36. K. L. Stanhope, J. M. Schwarz, N. L. Keim et al., "Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans, " Journal of Clinical Investigation, vol. 119, no. 5, pp. 1322-1334, 2009.
37. A. Spruss, G. Kanuri, S. Wagnerberger, S. Haub, S. C. Bischoff, and I. Bergheim, "Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice, " Hepatology, vol. 50, no. 4, pp. 1094-1104, 2009.
38. P. M. Nunes, A. J. Wright, A. Veltien et al., "Dietary lipids do not contribute to the higher hepatic triglyceride levels of fructosecompared to glucose-fed mice, " The FASEB Journal, vol. 28, no. 5, pp. 1988-1997, 2014.
39. D. G. Tiniakos, M. B. Vos, and E. M. Brunt, "Nonalcoholic fatty liver disease: pathology and pathogenesis, " Annual Review of Pathology: Mechanisms of Disease, vol. 5, pp. 145-171, 2010.
40. H. Tilg and A. R. Moschen, "Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis, " Hepatology, vol. 52, no. 5, pp. 1836-1846, 2010.
41. J. Henao-Mejia, E. Elinav, C. Jin et al., "Inflammasomemediated dysbiosis regulates progression of NAFLD and obesity, " Nature, vol. 482, no. 7384, pp. 179-185, 2012.
42. G. Szabo and T. Csak, "Inflammasomes in liver diseases, " Journal of Hepatology, vol. 57, no. 3, pp. 642-654, 2012.
43. K. Miura and H. Ohnishi, "Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease, " World Journal of Gastroenterology, vol. 20, no. 23, pp. 7381-7391, 2014.
44. E. Seki and B. Schnabl, "Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut, " Journal of Physiology, vol. 590, no. 3, pp. 447-458, 2012.
45. M. Ganz and G. Szabo, "Immune and inflammatory pathways in NASH, " Hepatology International, vol. 7, no. 2, supplement, pp. 771-781, 2013.
46. M. T. Lotze, H. J. Zeh, A. Rubartelli et al., "The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity, " Immunological Reviews, vol. 220, no. 1, pp. 60-81, 2007.
47. V. Bieghs and C. Trautwein, "The innate immune response during liver inflammation and metabolic disease, " Trends in Immunology, vol. 34, no. 9, pp. 447-452, 2013.
48. Y. S. Roh and E. Seki, "Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis, " Journal of Gastroenterology and Hepatology, vol. 28, supplement 1, pp. 38-42, 2013.
49. T. Luedde and R. F. Schwabe, "NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma, " Nature Reviews Gastroenterology and Hepatology, vol. 8, no. 2, pp. 108-118, 2011.
50. R. Meli, G. M. Raso, and A. Calignano, "Role of innate immune response in non-alcoholic fatty liver disease: metabolic complications and therapeutic tools, " Frontiers in Immunology, vol. 5, article 177, 2014.
51. J. Moretti and J. M. Blander, "Insights into phagocytosiscoupled activation of pattern recognition receptors and inflammasomes, " Current Opinion in Immunology, vol. 26, no. 1, pp. 100-110, 2014.
52. E. Seki, S. deMinicis, C. H. Osterreicher et al., "TLR4 enhances TGF-β signaling and hepatic fibrosis, " Nature Medicine, vol. 13, no. 11, pp. 1324-1332, 2007.
53. T. Csak, A. Velayudham, I. Hritz et al., "Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice, " The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 300, no. 3, pp. 433-441, 2011.
54. P. Cani, J. Amar, M. Iglesias, andM. Poggi, "Metabolic endotoxemia initiates obesity and insulin resistance, " Diabetes, vol. 56, pp. 1761-1772, 2007.
55. K. Miura, Y. Kodama, S. Inokuchi et al., "Toll-like receptor promotes steatohepatitis by induction of interleukin-1β in Mice, " Gastroenterology, vol. 139, no. 1, pp. 323.e7-334.e7, 2010.
56. H. Wen, D. Gris, Y. Lei et al., "Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling, " Nature Immunology, vol. 12, no. 5, pp. 408-415, 2011.
57. R. Stienstra, J. A. van Diepen, C. J. Tack et al., "Inflammasome is a central player in the induction of obesity and insulin resistance, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 37, pp. 15324-15329, 2011.
58. T. Csak, M. Ganz, J. Pespisa, K. Kodys, A. Dolganiuc, and G. Szabo, "Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells, " Hepatology, vol. 54, no. 1, pp. 133-144, 2011.
59. B. Vandanmagsar, Y.-H. Youm, A. Ravussin et al., "The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance, " Nature Medicine, vol. 17, no. 2, pp. 179-188, 2011.
60. K. E. Wellen and G. S. Hotamisligil, "Inflammation, stress, and diabetes, " Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111-1119, 2005.
61. L. Hammerich and F. Tacke, "Interleukins in chronic liver disease: lessons learned from experimental mouse models, " Clinical and Experimental Gastroenterology, vol. 7, pp. 297-306, 2014.
62. K. L. Streetz, F. Tacke, L. Leifeld et al., "Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases, " Hepatology, vol. 38, no. 1, pp. 218-229, 2003.
63. D. E. Malarkey, K. Johnson, L. Ryan, G. Boorman, and R. R. Maronpot, "New insights into functional aspects of liver morphology, " Toxicologic Pathology, vol. 33, no. 1, pp. 27-34, 2005.
64. Z. Kmiec, "Cooperation of liver cells in health and disease, " Advances in Anatomy, Embryology, and Cell Biology, vol. 161, pp. 3-13, 2001.
65. A. W. Thomson and P. A. Knolle, "Antigen-presenting cell function in the tolerogenic liver environment, " Nature Reviews Immunology, vol. 10, no. 11, pp. 753-766, 2010.
66. I. Klein, J. C. Cornejo, N. K. Polakos et al., "Kupffer cell heterogeneity: functional properties of bone marrow-derived and sessile hepatic macrophages, " Blood, vol. 110, no. 12, pp. 4077-4085, 2007.
67. F. O. Martinez, A. Sica, A. Mantovani, and M. Locati, "Macrophage activation and polarization, " Frontiers in Bioscience, vol. 13, no. 2, pp. 453-461, 2008.
68. L. J. Dixon, M. Barnes, H. Tang, M. T. Pritchard, and L. E. Nagy, "Kupffer cells in the liver, " Comprehensive Physiology, vol. 3, no. 2, pp. 785-797, 2013.
69. I. Bergheim, S. Weber, M. Vos et al., "Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin, " Journal of Hepatology, vol. 48, no. 6, pp. 983-992, 2008.
70. A. Leroux, G. Ferrere, V. Godie et al., "Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis, " Journal of Hepatology, vol. 57, no. 1, pp. 141-149, 2012.
71. T. Tang, Y. Sui, M. Lian, Z. Li, and J. Hua, "Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death, " PLoS ONE, vol. 8, no. 12, Article ID e81949, 2013.
72. W. Huang, A. Metlakunta, N. Dedousis et al., "Depletion of liver kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance, " Diabetes, vol. 59, no. 2, pp. 347-357, 2010.
73. K. Sawada, T. Ohtake, T. Hasebe et al., "Augmented hepatic Toll-like receptors by fatty acids trigger the pro-inflammatory state of non-alcoholic fatty liver disease in mice, " Hepatology Research, vol. 44, no. 8, pp. 920-934, 2014.
74. M. C. Arkan, A. L. Hevener, F. R. Greten et al., "IKK-β links inflammation to obesity-induced insulin resistance, " Nature Medicine, vol. 11, no. 2, pp. 191-198, 2005.
75. G. Solinas, C. Vilcu, J. G. Neels et al., "JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity, " Cell Metabolism, vol. 6, no. 5, pp. 386-397, 2007.
76. S. Lotersztajn, B. Julien, F. Teixeira-Clerc, P. Grenard, and A. Mallat, "Hepatic fibrosis: molecular mechanisms and drug targets, " Annual Review of Pharmacology and Toxicology, vol. 45, pp. 605-628, 2005.
77. P. Dongiovanni, S. Romeo, and L. Valenti, "Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors, " World Journal of Gastroenterology, vol. 20, no. 36, pp. 12945-12955, 2014.
78. C. Yin, K. J. Evason, K. Asahina, and D. Y. R. Stainier, "Hepatic stellate cells in liver development, regeneration, and cancer, " Journal of Clinical Investigation, vol. 123, no. 5, pp. 1902-1910, 2013.
79. R. Bataller and D. A. Brenner, "Liver fibrosis, " Journal of Clinical Investigation, vol. 115, no. 2, pp. 209-218, 2005.
80. J. P. Pradere, J. Kluwe, S. DeMinicis et al., "Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice, " Hepatology, vol. 58, no. 4, pp. 1461-1473, 2013.
81. J. A. Fallowfield, M. Mizuno, T. J. Kendall et al., "Scarassociated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis, " Journal of Immunology, vol. 178, no. 8, pp. 5288-5295, 2007.
82. J. S. Duffield, S. J. Forbes, C. M. Constandinou et al., "Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair, " Journal of Clinical Investigation, vol. 115, no. 1, pp. 56-65, 2005.
83. P. Ramachandran, A. Pellicoro, M. A. Vernon et al., "Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression ofmurine liver fibrosis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 46, pp. E3186-E3195, 2012.
84. A. Mallat, J. Lodder, F. Teixeira-Clerc, R. Moreau, P. Codogno, and S. Lotersztajn, "Autophagy: a multifaceted partner in liver fibrosis, " BioMed Research International, vol. 2014, Article ID 869390, 7 pages, 2014.